Anti-inflammatory activity of thiamine and nicotinic acid.
D000410:Alanine Transaminase / Q000037:antagonists & inhibitors; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000037:antagonists & inhibitors; D002118:Calcium; D002351:Carrageenan; D004396:Coloring Agents / Q000097:blood; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy* / Q000201:enzymology; D005557:Formaldehyde; D006099:Granuloma / Q000139:chemically induced / Q000188:drug therapy* / Q000201:enzymology; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000627:therapeutic use; D051381:Rats; D013831:Thiamine / Q000494:pharmacology / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D004396:Coloring Agents; D009539:Nicotinic Acids; D005557:Formaldehyde; D002351:Carrageenan; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D010653:Phenylbutazone; D002118:Calcium; D013831:Thiamine